Blood vessel effects of empagliflozin in adults with high-normal blood pressure
Treatments studied
Part of Heart & circulation clinical trials.
This study tests a diabetes medication called empagliflozin to see if it helps improve the health of blood vessels in people with slightly elevated blood pressure. It may help protect blood vessels from damage that can lead to heart problems later.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 45 and 75 years old
- Your body mass index (BMI) must be between 18 and 35
- Your blood pressure should be normal or slightly elevated (top number under 130, bottom number under 80) — if you're diagnosed with high blood pressure, you won't qualify
- You cannot have type 2 diabetes
- You cannot have a history of heart attack, heart failure, stroke, or other major heart or brain conditions
- You must be a non-smoker (no tobacco or cannabis use now or in the past 6 months)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called empagliflozin (a type of drug that helps protect the kidneys) can improve blood vessel health in people with chronic kidney disease who do not have diabetes. It may help slow kidney decline and reduce heart risks.
This study tests whether a medication called empagliflozin (a diabetes drug) can improve heart function in older adults with high blood pressure and obesity who are at risk for heart failure but do not have it yet. You would take the pill daily and have heart ultrasounds to check your heart's health.
This study tests if a diabetes medication, empagliflozin, can reduce age-related stiffening of arteries in people without diabetes. If you are between 60 and 80 and have stiff arteries, this trial could help improve your vascular health.
This study looks at whether empagliflozin, a diabetes medicine, helps improve blood flow in tiny blood vessels for people in cardiogenic shock. If it helps, it could improve recovery for people with this serious heart condition.
This trial tests if empagliflozin, a medication typically used for diabetes, can help people with metabolic syndrome (a cluster of conditions like large waist size, high blood sugar, and high blood pressure). It may improve health and reduce the risk of heart disease.
This study tests whether a diabetes drug (empagliflozin) can improve the heart's ability to relax and fill with blood in people with non-obstructive hypertrophic cardiomyopathy, a type of heart muscle thickening. You may be able to join if you have this condition and are not currently taking an SGLT2 inhibitor.
Hear when a new Blood Pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.